Bacteriophage assays for rifampicin resistance detection in Mycobacterium tuberculosis: Updated meta-analysis

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 8, 2010, Pages 941-951

  Minion, J ^a   Pai, Madhukar ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Bacteriophage assays; Diagnosis; MDR TB; Rifampicin; Tuberculosis

Indexed keywords

AZTREONAM; NYSTATIN; OXACILLIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC THERAPY; BACTERIOPHAGE; BACTERIUM DETECTION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; HUMAN; META ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; OUTCOME ASSESSMENT; PERFORMANCE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TUBERCULOSIS; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; MICROBIOLOGY; MYCOBACTERIOPHAGE; PHYSIOLOGY; TUBERCULOSIS, MULTIDRUG-RESISTANT; VIROLOGY;

ANTIBIOTICS, ANTITUBERCULAR; DRUG RESISTANCE, BACTERIAL; HUMANS; MYCOBACTERIOPHAGES; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 77954739695     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. MMWR 2006; 55: 301-305.
2. Espinal M A. The global situation of MDR-TB. Tuberculosis (Edinb) 2003; 83: 44-51.
3. Pai M, O'Brien R. New diagnostics for latent and active tuberculosis: state of the art and future prospects. Semin Respir Crit Care Med 2008; 29: 560-568.
4. Grandjean L, Moore D A. Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis. Curr Opin Infect Dis 2008; 21: 454-461.
5. Trollip A, Albert H, Maskell T. Bacteriophage-based technologies for the rapid diagnosis and drug susceptibility testing of tuberculosis. Am Clin Lab 2001; 20: 39-42.
6. Pai M, Kalantri S, Pascopella L, Riley L W, Reingold A L. Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J Infect 2005; 51: 175-187.
7. Pai M, McCulloch M, Enanoria W, Colford J M Jr. Systematic reviews of diagnostic test evaluations: what's behind the scenes? ACP J Club 2004; 141: A11-A13.
8. Hadgu A. Discrepant analysis is an inappropriate and unscientific method. J Clin Microbiol 2000; 38: 4301-4302.
9. Kalantri S, Pai M, Pascopella L, Riley L, Reingold A. Bacteriophage- based tests for the detection of Mycobacterium tuberculosis in clinical specimens: a systematic review and meta-analysis. BMC Infect Dis 2005; 5: 59.
10. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6: 31. (Pubitemid 44285240)
11. Littenberg B, Moses L E. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making 1993; 13: 313-321. (Pubitemid 24013154)
12. Reitsma J B, Glas A S, Rutjes A W, Scholten R J, Bossuyt P M, Zwinderman A H. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005; 58: 982-990.
13. Harbord R, Whiting P. Metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression. In: Sterne J, editor. Meta-analysis in Stata: an updated collection from the Stata journal. College Station, TX, USA: Stata Press, 2009: pp 181-199.
14. Albert H, Heydenrych A, Mole R, Trollip A, Blumberg L. Evaluation of FASTPlaqueTB-RIF, a rapid, manual test for the d etermination of rifampicin resistance from Mycobacterium tuberculosis cultures. Int J Tuberc Lung Dis 2001; 5: 906-911.
15. Aktepe O, Altindis M, Esen N, eds. A rapid method of rifampin susceptibility testing of Mycobacterium tuberculosis. Istanbul, Turkey: 11th European Congress of Clinical Microbiology and Infectious Diseases, 2001.
16. Albert H, Trollip A P, Mole R J, Hatch S J, Blumberg L. Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FASTPlaqueTB-RIF, a manual phage-based test. Int J Tuberc Lung Dis 2002; 6: 523-528.
17. Krishnamurthy A, Rodrigues C, Mehta A P. Rapid detection of rifampicin resistance in M. tuberculosis by phage assay. Indian J Med Microbiol 2002; 20: 211-214.
18. Oguz V, Guneri S, Erdenizmenli M, et al. Investigation of rifampin resistance in Mycobacterium tuberculosis by two different methods. Toraks Dergisi 2002; 3: 173-177.
19. Kisa O, Albay A, Bedir O, Baylan O, Doganci L. Evaluation of FASTPlaqueTB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates. Int J Tuberc Lung Dis 2003; 7: 284-288.
20. Butt T, Ahmad R N, Afzal R K, Mahmood A, Anwar M. Rapid detection of rifampicin susceptibility of Mycobacterium tuberculosis in sputum specimens by mycobacteriophage assay. J Pak Med Assoc 2004; 54: 379-382.
21. Albert H, Trollip A, Seaman T, Mole R J. Simple, phage-based (FASTPlaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum. Int J Tuberc Lung Dis 2004; 8: 1114-1119.
22. Albert H, Trollip A P, Linley K, Abrahams C, Seaman T, Mole R J. Development of an antimicrobial formulation for control of specimen-related contamination in phage-based diagnostic testing for tuberculosis. J Appl Microbiol 2007; 103: 892-899. (Pubitemid 47493242)
23. Albert H, Trollip A P, Seaman T, et al. Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape. S Afr Med J 2007; 97: 858-863. (Pubitemid 47542655)
24. Mole R, Trollip A, Abrahams C, Bosman M, Albert H. Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis. J Med Microbiol 2007; 56: 1334-1339.
25. Wilson S M, al-Suwaidi Z, McNerney R, Porter J, Drobniewski F. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat Med 1997; 3: 465-468.
26. Eltringham I J, Drobniewski F A, Mangan J A, Butcher P D, Wilson S M. Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol 1999; 37: 3524-3527.
27. McNerney R, Kiepiela P, Bishop K S, Nye P M, Stoker N G. Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin. Int J Tuberc Lung Dis 2000; 4: 69-75.
28. Gali N, Dominguez J, Blanco S, et al. Utility of an in-house mycobacteriophage-based assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis clinical isolates. J Clin Microbiol 2003; 41: 2647-2679.
29. Mani C, Selvakumar N, Kumar V, Narayanan S, Narayanan P R. Comparison of DNA sequencing, PCR-SSCP and PhaB assays with indirect sensitivity testing for detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2003; 7: 652-659. (Pubitemid 36806860)
30. Simboli N, Takiff H, McNerney R, et al. In-house phage amplification assay is a sound alternative for detecting rifampinresistant Mycobacterium tuberculosis in low-resource settings. Antimicrob Agents Chemother 2005; 49: 425-427.
31. da Silva P A, Boffo M M, de Mattos I G, et al. Comparison of redox and D29 phage methods for detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 2006; 12: 293-296.
32. Yzquierdo S L, Lemus D, Echemendia M, et al. Evaluation of phage assay for rapid phenotypic detection of rifampicin resistance in Mycobacterium tuberculosis. Ann Clin Microbiol Antimicrob 2006; 5: 11.
33. Chauca J A, Palomino J C, Guerra H. Evaluation of rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis by a mycobacteriophage D29-based assay. J Med Microbiol 2007; 56: 360-364.
34. Traore H, Ogwang S, Mallard K, et al. Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda. Ann Clin Microbiol Antimicrob 2007; 6: 1. (Pubitemid 46218601)
35. McNerney R, Mallard K, Urassa H M, Lemma E, Donoghue H D. Colorimetric phage-based assay for detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007; 45: 1330-1332.
36. Ogwang S, Asiimwe B B, Traore H, et al. Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda. BMC Infect Dis 2009; 9: 139.
37. Riska P F, Su Y, Bardarov S, et al. Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box. J Clin Microbiol 1999; 37: 1144-1149.
38. Lu B, Fu Z, Xu S. Rapid rifampin susceptibility test by using recombinant mycobacteriophages. Zhonghua Jie He He Hu Xi Za Zhi 2000; 23: 480-484.
39. Banaiee N, Bobadilla-Del-Valle M, Bardarov S Jr, et al. Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico. J Clin Microbiol 2001; 39: 3883-3888.
40. Banaiee N, Bobadilla-del-Valle M, Riska P F, et al. Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages. J Med Microbiol 2003; 52: 557-561.
41. Hazbon M H, Guarin N, Ferro B E, et al. Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 2003; 41: 4865-4869.
42. Bardarov S Jr, Dou H, Eisenach K, et al. Detection and drug susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage: comparison with the Mycobacteria Growth Indicator Tube (MGIT) system. Diagn Microbiol Infect Dis 2003; 45: 53-61.
43. Banaiee N, January V, Barthus C, et al. Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South Africa. Tuberculosis (Edinb) 2008; 88: 64-68.
44. Fontela P S, Pant Pai N, Schiller I, Dendukuri N, Ramsay A, Pai M. Quality and reporting of diagnostic accuracy studies in TB, HIV and malaria: evaluation using QUADAS and STARD standards. PLoS ONE 2009; 4: e7753.
45. Mbulo G M, Kambashi B S, Kinkese J, et al. Comparison of two bacteriophage tests and nucleic acid amplification for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa. Int J Tuberc Lung Dis 2004; 8: 1342-1347. (Pubitemid 39611580)
46. Muzaffar R, Batool S, Aziz F, Naqvi A, Rizvi A. Evaluation of the FASTPlaqueTB assay for direct detection of Mycobacterium tuberculosis in sputum specimens. Int J Tuberc Lung Dis 2002; 6: 635-640.
47. Albay A, Kisa O, Baylan O, Doganci L. The evaluation of FASTPlaqueTB test for the rapid diagnosis of tuberculosis. Diagn Microbiol Infect Dis 2003; 46: 211-215.
48. Bonnet M, Gagnidze L, Varaine F, Ramsay A, Githui W, Guerin P J. Evaluation of FASTPlaqueTB™ to diagnose smear-negative tuberculosis in a peripheral clinic in Kenya. Int J Tuberc Lung Dis 2009; 13: 1112-1128.
49. Foundation for Innovative New Diagnostics (FIND). FIND interrupts demonstration projects using phage-based assays for detection of rifampin resistance. Geneva, Switzerland: FIND, 3 October 2007. http://www. finddiagnostics.org/media/news/ index.jsp?year=2007&domain= Accessed May 2010.
50. Trollip A P, Albert H, Mole R, Marshall T, van Cutsem G, Coetzee D. Performance of FASTPlaqueTB and a modified protocol in a high HIV prevalence community in South Africa. Int J Tuberc Lung Dis 2009; 13: 791-793.
51. Ling D I, Zwerling A A, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 2008; 32: 1165-1174.
52. World Health Organization. Policy statement. Molecular line probe assays for rapid screening of patients at risk of multidrug- resistant tuberculosis (MDR-TB). Geneva, Switzerland: WHO, 2008. http: //www.who.int/tb/features- archive/policy-statement.pdf Accessed May 2010.
53. World Health Organization. Strategic and Technical Advisory Group for Tuberculosis (STAG-TB). Report of the 9th meeting. November 9-11, 2009. Geneva, Switzerland: WHO, 2009. http://www.who.int/tb/advisory-bodies/stag-tb-report- 2009. pdf Accessed May 2010.